Clinical Guide

How to Use NLP in Suicide Risk Assessment Safely

How should clinicians incorporate natural language processing into suicide risk assessment without replacing validated clinical screening?

Suicide risk often fluctuates between visits, and structured assessments performed only at discrete encounters may miss imminent or evolving danger. The article describes a practical model in which validated suicide screening remains foundational while NLP and machine learning add continuous detection of real-world risk signals.

  1. Start with a validated suicide assessment tool

    Use a gold-standard instrument such as the Columbia Suicide Severity Rating Scale as the foundation of suicide risk assessment. The article emphasizes that validated tools remain foundational even as NLP- and machine learning-based approaches are developed.

  2. Add NLP or machine learning as an adjunct, not a replacement

    Incorporate NLP- or machine learning-based prediction to capture dynamic risk signals that structured retrospective self-report may miss outside formal assessments. The article describes NLP as a way to analyze longitudinal, real-world free-text data and update predictions continuously over time.

  3. Use real-world text sources to identify dynamic risk markers

    Apply NLP to sources such as free-text clinical narratives in the electronic health record and, where available, patient portal messages. The article notes that these approaches can model dynamic risk trajectories and capture contextual and linguistic markers of distress, and that in one study message sentiment was a stronger predictor of 30-day suicide-related events than individual keywords.

  4. Integrate face-to-face screening with real-time EHR prediction

    Combine clinician-administered screening with real-time EHR-based machine learning prediction rather than relying on either alone. In a cohort of more than 120,000 adult patient encounters, the article reports that suicide risk detection was most effective when face-to-face Columbia Suicide Severity Rating Scale screening was integrated with real-time EHR-based machine learning models using the Vanderbilt Suicide Attempt and Ideation Likelihood prediction tool.

  5. Use predictions for short-term stratification and follow-up planning

    Interpret NLP- and machine learning-generated risk outputs as tools for short-term risk stratification with clinically actionable response horizons measured in weeks to months. The article states that early research indicates these models can outperform clinician checklists and traditional scales in short-term risk stratification, but they still require careful clinical integration.

  6. Do not rely on generative AI chatbots for suicide triage

    Avoid using general-purpose or patient-facing generative AI chatbots as stand-alone suicide triage tools. The article reports that none of 29 tested chatbot agents met initial criteria for an adequate response to simulated suicidal risk scenarios, common errors included failure to provide emergency contact information, and large language model responses were inconsistent for intermediate-risk suicide queries.

Clinical Considerations

  • Traditional validated suicide assessment tools remain foundational despite the promise of NLP- and machine learning-based approaches.
  • Although early studies are promising, the clinical efficacy of machine learning-based suicide prediction remains uncertain and requires real-world validation.
  • Large language model chatbots aligned better with expert judgment at very low or very high suicide risk than at intermediate-risk levels.
  • Ethical and implementation concerns must be addressed when integrating NLP and machine learning into care settings.

Bottom Line

Use NLP and machine learning to augment, not replace, validated suicide screening, with the strongest approach being integrated clinician assessment plus real-time EHR-based prediction.

Read full article
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.